Christopher Morabito, CMO at Fulcrum Therapeutics, holds 0.00 shares in Astria Therapeutics (Ticker: ATXS), holds 1.10K shares in Fulcrum Therapeutics (Ticker: FULC).

See the Hottest Stocks Based on Insider Trading >

Christopher Morabito
Fulcrum Therapeutics (FULC)
CMO

Not Ranked

Christopher Morabito has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

100.00%

FULC

0.00%

ATXS

A breakdown of Christopher Morabito's holdings

See the Top Stocks by Insiders

Insider Roles

Fulcrum Therapeutics
(FULC)

CMO

Astria Therapeutics
(ATXS)

CMO

Roles that Christopher Morabito holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Fulcrum Therapeutics
(FULC)

Rating:Informative Buy

Date:Jun 29, 2021 - Jun 29, 2022

Return:-47.90%

The most profitable trade made by Christopher Morabito

See the Latest Stocks Traded by Insiders

Christopher Morabito's Trading History

FULC

Fulcrum Therapeutics

Jun 29, 2021

CMO

Informative Buy

10.08K

$7.84K

ATXS

Astria Therapeutics

Apr 03, 2024

CMO

Uninformative Sell

135.90K

$0.00

List of latest transactions for each holding click on a transaction to see Christopher Morabito's performance on stock

See All Insider Trading from Today

Christopher Morabito insider profile FAQ

What is the percentage of profitable transactions made by Christopher Morabito?

The percentage of profitable transactions made by Christopher Morabito is ―.

What is the average return per transaction made by Christopher Morabito?

The average return per transaction made by Christopher Morabito is ―.

What stocks does Christopher Morabito hold?

Christopher Morabito holds: FULC, ATXS stocks.

What was Christopher Morabito’s latest transaction?

Christopher Morabito latest transaction was an Uninformative Sell of $135.90K.

What was Christopher Morabito's most profitable transaction?

Christopher Morabito’s most profitable transaction was an Informative Buy of FULC stock on June 29, 2021. The return on the trade was -47.90%.

What is Christopher Morabito's role in Fulcrum Therapeutics?

Christopher Morabito's role in Fulcrum Therapeutics is CMO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Christopher Morabito Insider Profile

Christopher Morabito Fulcrum Therapeutics (FULC)CMO